Free Trial

Cibus Q3 2024 Earnings Report

Cibus logo
$2.54 -0.09 (-3.42%)
As of 01:18 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Cibus EPS Results

Actual EPS
$0.06
Consensus EPS
-$0.89
Beat/Miss
Beat by +$0.95
One Year Ago EPS
-$1.59

Cibus Revenue Results

Actual Revenue
$1.67 million
Expected Revenue
$0.47 million
Beat/Miss
Beat by +$1.20 million
YoY Revenue Growth
N/A

Cibus Announcement Details

Quarter
Q3 2024
Time
After Market Closes

Conference Call Resources

Cibus Earnings Headlines

Cibus director Gerhard Prante sells $5,531 in stock
Most People Are Dead Wrong.
Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines about artificial intelligence. Everyone's talking about AI right now. But see, I've been talking about it for years.
Cibus price target lowered to $18 from $20 at Canaccord
Cibus to Participate in the Sidoti Micro Cap Conference
See More Cibus Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Cibus? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cibus and other key companies, straight to your email.

About Cibus

Cibus (NASDAQ:CBUS), a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. Cibus, Inc. is based in San Diego, California.

View Cibus Profile

More Earnings Resources from MarketBeat